ArticleMedical oncology (Northwood, London, England)2025
Siphonaxanthin inhibits the growth of breast cancer cell subtypes by modulating the expression of cellular proteins associated with antioxidant defence, cell survival and apoptosis signaling.
Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The marine green algae, Codium species, have a long-standing history of use in Japanese and Korean food culture. Recent reports reveal that extracts/isolated compounds of Codium species exhibited immunostimulatory, anti-obese, and anticancer effects. This study aimed to delineate the molecular mechanism underlying the growth inhibitory effect of siphonaxanthin (SPX) isolated from Coduim sp. in luminal (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells. The cell viability was measured by WST-1 assay. The protein expression of the markers of antioxidant defense, cell survival, and apoptosis signaling pathways was analyzed by western blotting. The apoptosis induction by carotenoids was visualized using DAPI staining. The results showed that purified SPX inhibited the viability of MCF-7 and MDA-MB-231 cells at a concentration of 5 μM. The growth inhibitory effect of SPX was associated with suppressed protein expression of antioxidant enzyme, SOD-2, and its transcription factor, Nrf2. Carotenoid treatment subsequently blocked the expression of intracellular cell survival markers such as pAkt and pERK1/2, and a redox-sensitive transcription factor NF-kB. Further, suppression of antioxidant defence and cell survival markers was linked with apoptosis induction, with downregulated expression of Bcl-2, p-Bad, and PARP. Collectively, our results highlight a significant cancer chemopreventive role of marine carotenoid SPX in human breast cancer cells and demonstrate that it activates cell death partly through the modulation of antioxidant defense response-linked cell survival signaling markers.
Indexed as
Identifiers
40515862What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.